Danaher Corporation (NYSE:DHR) is one of the 14 Best Large Cap Stocks to Invest In Now. On December 9, Goldman Sachs started ...

Danaher (NYSE: DHR) has outperformed the market over the past 10 years by 1.08% on an annualized basis producing an average annual return of 13.82%. Currently, Danaher has a market capitalization of ...

While not a mind-blowing move, it is good to see that the Danaher Corporation ( NYSE:DHR ) share price has gained ...

Industrial and medical equipment maker Danaher said Thursday that its third-quarter net income climbed 9 percent as revenue increased. Its results topped analysts' expectations. NUMBERS: For the three ...

Danaher (NYSE:DHR) delivers biotechnology, medical, and industrial solutions with global operational reach, structured ...

Danaher is one of those big companies few people know about other than investors, and that's despite the fact that it owns a big portfolio of biotech, diagnostics and life sciences brands. But the ...

Financial giants have made a conspicuous bearish move on Danaher. Our analysis of options history for Danaher (NYSE:DHR) revealed 14 unusual trades. Delving into the details, we found 28% of traders ...

It’s a sale. Two months after Abcam launched a strategic review of the company, the British antibody research expert has revealed that it’s being bought by Danaher. Danaher Corporation is picking up ...

Danaher Corporation, a key player in Life Sciences, Biotechnology, and Diagnostics, has shown mixed financial performance with recent declines in revenue and net earnings. Despite recent struggles, ...